| scholarly article | Q13442814 |
| P2093 | author name string | Abe M | |
| Nakazawa T | |||
| Oguri T | |||
| Ouchi K | |||
| Karita M | |||
| Igari J | |||
| P2860 | cites work | An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump | Q68419346 |
| Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes | Q69784331 | ||
| Colonization and. Infection with Pseudomonas cepacia | Q70401441 | ||
| Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with contaminated nebulizer devices | Q71604232 | ||
| Proposal of Burkholderia gen. nov. and Transfer of Seven Species of the Genus Pseudomonas Homology Group II to the New Genus, with the Type Species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov | Q28184131 | ||
| Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia | Q35109288 | ||
| Insertion-sequence-dependent rearrangements of Pseudomonas cepacia plasmid pTGL1. | Q36226718 | ||
| Rapid procedure for detection and isolation of large and small plasmids | Q36320743 | ||
| Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis | Q37083296 | ||
| Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping | Q37125372 | ||
| DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak | Q37232474 | ||
| O and H serotyping of Pseudomonas cepacia | Q37257397 | ||
| Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements. | Q39930322 | ||
| Characterization of hemolysin in extracellular products of Pseudomonas cepacia | Q40189264 | ||
| Subgrouping of Pseudomonas cepacia by cellular fatty acid composition | Q40197580 | ||
| Typing of Pseudomonas cepacia by bacteriocin susceptibility and production | Q40204325 | ||
| Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination | Q43655857 | ||
| Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. | Q44831840 | ||
| Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia. | Q54223179 | ||
| A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. | Q54754065 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2353-2357 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing | |
| P478 | volume | 33 |
| Q81605900 | Aerobic gram-negative bacilli: newer nosocomial pathogens |
| Q39457387 | Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping. |
| Q51652420 | Epidemiologic Investigation ofBurkholderia cepaciaAcquisition in Two Pediatric Intensive Care Units |
| Q40014199 | Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers |
| Q29615286 | Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia |
| Q74346598 | Molecular epidemiology of Burkholderia cepacia in two Australian cystic fibrosis centres |
| Q43734987 | The structure of a polysaccharide from infectious strains of Burkholderia cepacia |
Search more.